|
MCI (mild cognitive impairment)
Citations 91-100 of 131 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
APOE genotype and cognitive decline in a middle-aged cohort
- C. K. Blair, A. R. Folsom, D. S. Knopman, M. S. Bray, T. H. Mosley, E. Boerwinkle for the Atherosclerosis Risk in Communities Study Investigators
Neurology 2005; 64: 268-276.
[Abstract]
[Full text]
[PDF]
- ARTICLES
MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET
- L. Mosconi, D. Perani, S. Sorbi, K. Herholz, B. Nacmias, V. Holthoff, E. Salmon, J.-C. Baron, M. T.R. De Cristofaro, A. Padovani, B. Borroni, M. Franceschi, L. Bracco, and A. Pupi
Neurology 2004; 63: 2332-2340.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Preclinical Alzheimer disease: Neuropsychological test performance 1.5 to 8 years prior to onset
- J. Saxton, O. L. Lopez, G. Ratcliff, C. Dulberg, L. P. Fried, M. C. Carlson, A. B. Newman, and L. Kuller
Neurology 2004; 63: 2341-2347.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease
- J. Olazarán, R. Muñiz, B. Reisberg, J. Peña-Casanova, T. del Ser, A. J. Cruz-Jentoft, P. Serrano, E. Navarro, M. L. García de la Rocha, A. Frank, M. Galiano, Y. Fernández-Bullido, J. A. Serra, M. T. González-Salvador, and C. Sevilla
Neurology 2004; 63: 2348-2353.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Vascular risk factors, incidence of MCI, and rates of progression to dementia
- V. Solfrizzi, F. Panza, A. M. Colacicco, A. D’Introno, C. Capurso, F. Torres, F. Grigoletto, S. Maggi, A. Del Parigi, E. M. Reiman, R. J. Caselli, E. Scafato, G. Farchi, A. Capurso for the Italian Longitudinal Study on Aging Working Group
Neurology 2004; 63: 1882-1891.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Impact of APOE in mild cognitive impairment
- M. R. Farlow, Y. He, S. Tekin, J. Xu, R. Lane, and H. C. Charles
Neurology 2004; 63: 1898-1901.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Size does matter in the long run: Hippocampal and cortical volume predict recall across weeks
- K. B. Walhovd, A. M. Fjell, I. Reinvang, A. Lundervold, B. Fischl, B. T. Quinn, and A. M. Dale
Neurology 2004; 63: 1193-1197.
[Abstract]
[Full text]
[PDF]
- ARTICLES
APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging
- D. Bunce, L. Fratiglioni, B. J. Small, B. Winblad, and L. Bäckman
Neurology 2004; 63: 816-821.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Plasma levels of amyloid ß-protein 42 are increased in women with mild cognitive impairment
- A. Assini, S. Cammarata, A. Vitali, M. Colucci, L. Giliberto, R. Borghi, M. L. Inglese, S. Volpe, S. Ratto, F. Dagna-Bricarelli, C. Baldo, A. Argusti, P. Odetti, A. Piccini, and M. Tabaton
Neurology 2004; 63: 828-831.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Efficacy of donepezil in mild cognitive impairment: A randomized placebo-controlled trial
- S. Salloway, S. Ferris, A. Kluger, R. Goldman, T. Griesing, D. Kumar, and S. Richardson
Neurology 2004; 63: 651-657.
[Abstract]
[Full text]
[PDF]
|
|
